Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rociverine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.